发明名称 Combinations of tiotropium bromide, formoterol and budesonide for the treatment of copd
摘要 This invention provides a fixed-dose composition comprising formoterol or a pharmaceutically acceptable salt thereof and budesonide, for use in the long-term treatment of COPD and the treatment of acute exacerbations of COPD, wherein the composition is administered as a maintenance dose for the long-term treatment of COPD and pro re nata (p.r.n.) as a rescue medication for the treatment of acute exacerbations of COPD.
申请公布号 IL248874(D0) 申请公布日期 2017.01.31
申请号 IL20160248874 申请日期 2016.11.09
申请人 TEVA PHARMACEUTICALS EUROPE B.V.;MICHIEL ULLMANN 发明人 MICHIEL ULLMANN
分类号 A61K 主分类号 A61K
代理机构 代理人
主权项
地址